DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

KRM Ayurveda Limited — Updates

NSE 16 hrs ago·20 Jul 2026, 11:14 am

KRM Ayurveda

KRM Ayurveda Limited has informed stock exchanges about the sale of one of its properties under SEBI's Regulation 30. This disclosure is a standard requirement for listed companies to ensure transparency regarding major corporate actions.

For investors, this news signals a potential shift in the company's asset base. Selling property can impact the company's cash flow and long-term capital structure. It may also indicate a strategic move to monetize non-core assets or raise funds for expansion.

Investors should monitor the company's future announcements to understand the specific reason behind the sale. This will help in assessing whether the move is intended to strengthen the company's financial position or fund new growth initiatives.